News

How AI-Powered Imaging Systems Are Solving Healthcare’s Radiologist Shortage Crisis

Yuvraj — Tue, 25 Aug 2026 10:22:11 +0000

Healthcare systems face growing imaging volumes and a limited number of radiology specialists to handle them. AI-powered imaging systems can help close this gap by streamlining routine tasks and giving radiologists more time for complex cases and clinical decisions. Here’s how these systems can increase your radiologist capacity and support faster, more efficient imaging workflows. […]

The post How AI-Powered Imaging Systems Are Solving Healthcare’s Radiologist Shortage Crisis first appeared on World Pharma Today.

Eli Lilly’s $3.5 Billion Manufacturing Campus Advances in Upper Macungie, Pennsylvania

Yuvraj — Fri, 21 Aug 2026 13:33:12 +0000

A planned $3.5 billion pharmaceutical manufacturing campus in Upper Macungie Township, Pennsylvania, has advanced through the local development process after the Upper Macungie Planning Commission recommended final subdivision and land development approval on August 19, 2026. Known as Project Kennedy, the development by Eli Lilly calls for a 797,432-square-foot manufacturing campus on approximately 150 acres […]

The post Eli Lilly’s $3.5 Billion Manufacturing Campus Advances in Upper Macungie, Pennsylvania first appeared on World Pharma Today.

Overcoming Resistance-Associated Substitutions (RASs) to Direct-Acting Antivirals

Yuvraj — Fri, 21 Aug 2026 07:34:25 +0000

Alt tag: Scientific illustration of Hepatitis C virus interacting with a human liver cell, showing host-targeting molecules disrupting viral entry, replication, and lipid-dependent assembly to overcome antiviral resistance. While the introduction of Direct-Acting Antivirals has helped cure Hepatitis C, making it a major milestone in global health, mutation in the virus remains a persistent clinical […]

The post Overcoming Resistance-Associated Substitutions (RASs) to Direct-Acting Antivirals first appeared on World Pharma Today.

Genentech Completes Structural Framework at New NC Manufacturing Facility

Yuvraj — Thu, 20 Aug 2026 12:46:41 +0000

Genentech raised the final beam of its new Holly Springs, North Carolina manufacturing facility on August 18, marking the completion of the structural framework for what will become the company’s first East Coast manufacturing site in the United States. The topping out ceremony represents an on-time construction milestone for Genentech, a member of the Roche […]

The post Genentech Completes Structural Framework at New NC Manufacturing Facility first appeared on World Pharma Today.

Chugai Pharmaceutical and GSK Sign Exclusive License Agreement for Anti-Dengue Antibody AID351

Yuvraj — Thu, 20 Aug 2026 07:22:24 +0000

Japan-based Chugai Pharmaceutical has entered into an exclusive license agreement with British pharmaceutical company GlaxoSmithKline (GSK) for the anti-dengue virus antibody known as AID351, in a move that advances global efforts to combat one of the world’s most widespread tropical diseases. Under the terms of the agreement, GSK obtains an exclusive, worldwide license from Chugai […]

The post Chugai Pharmaceutical and GSK Sign Exclusive License Agreement for Anti-Dengue Antibody AID351 first appeared on World Pharma Today.

Lonza Launches Rapid Media Prototyping Service to Accelerate Biopharmaceutical Development

Yuvraj — Wed, 19 Aug 2026 13:38:24 +0000

Lonza has announced the launch of its Rapid Media Prototyping Service (RaMP) — a solution designed to give biopharmaceutical companies faster access to custom liquid and powder media for screening, process confirmation, and early development. Delivering Speed and Flexibility in Early Development The new service enables the production of non-GMP powder batches ranging from 1 […]

The post Lonza Launches Rapid Media Prototyping Service to Accelerate Biopharmaceutical Development first appeared on World Pharma Today.

Sandoz Expands Global Pipeline with Multi-Product Biosimilar Agreement

Yuvraj — Mon, 17 Aug 2026 14:11:23 +0000

Sandoz has entered into a collaboration agreement with Shanghai Henlius Biotech to co-develop a series of new biosimilars across international markets. The milestone-based transaction carries a total consideration of up to $322m, including near-term payments of up to $100.5m associated with initial product candidates. Under the terms of this biosimilar collaboration, Henlius will oversee development […]

The post Sandoz Expands Global Pipeline with Multi-Product Biosimilar Agreement first appeared on World Pharma Today.

Axtria Scales Forward Deployed Engineering Team to 1,000 Experts

Yuvraj — Thu, 13 Aug 2026 13:41:28 +0000

Global data analytics provider Axtria Inc. announced plans on August 13, 2026, to expand its Forward Deployed Engineering organization to 1,000 engineers by December 2026. This expansion creates the industry’s largest pharma AI engineering initiative, addressing growing customer demand to deploy, scale, and operationalize enterprise artificial intelligence across commercial, medical, and market access functions. The […]

The post Axtria Scales Forward Deployed Engineering Team to 1,000 Experts first appeared on World Pharma Today.

FDA Releases Proposed Commitment Letter for Next Generic Drug User Fee Agreement

Yuvraj — Thu, 13 Aug 2026 12:31:11 +0000

Following months of negotiations with industry stakeholders, the US Food and Drug Administration (FDA) has published its proposed commitment letter for the GDUFA IV program. Announced in the Federal Register on Monday alongside details for an upcoming public meeting, the proposal introduces strategic initiatives to promote domestic manufacturing, implement a modernized meeting structure, and reduce […]

The post FDA Releases Proposed Commitment Letter for Next Generic Drug User Fee Agreement first appeared on World Pharma Today.

Buying Guide: How to Source High-Quality Selank for Research

Yuvraj — Sat, 08 Aug 2026 07:36:36 +0000

Peptide research continues to expand across academic and independent laboratory settings, and with that growth comes an increasing need for reliable sourcing practices. Selank, a synthetic peptide studied in neuroscience and behavioral research contexts, is one of many compounds where sourcing quality directly affects experimental outcomes. This guide outlines the key factors researchers should evaluate […]

The post Buying Guide: How to Source High-Quality Selank for Research first appeared on World Pharma Today.